Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Tobacco Virus Protects Against Parkinson’s Disease

By BiotechDaily International staff writers
Posted on 15 Apr 2013
Print article
A virus typically associated with tobacco, but also present in spinach, tomatoes, petunias, and other household plants and vegetables, may help protect people from Parkinson’s disease.

Researchers from the University of Louisville’s (UofL; KY, USA) departments of neurology and physiology in a study published on April 3, 2013, in the journal PLOS One revealed that men who smoke have antibodies to the tobacco mosaic virus (TMV). These antibodies may interact with a protein in a cell’s energy generation system and inhibit the development of Parkinson’s disease.

Significantly, according to the researchers, this is the first reporting of the presence of antibodies to TMV in humans. Ruolan Liu, MD, PhD, Radhika Vaishnav, PhD, Andrew Roberts, PhD, and Robert Friedland, MD, examined blood samples of 60 men, 20 each who were smokeless tobacco users, smokers, or non-tobacco users. The researchers found the highest levels of the antibodies to TMV in those who smoked.

“It is quite remarkable that a plant that creates so many health problems for people may harbor a virus that has a protective role for people,” remarked Dr. Friedland, professor of neurology at the University of Louisville and the senior author for the study. “We still have a significant amount of research to undertake to determine what mechanisms may be involved, the molecular pathways that are in play and much more. However, it is valuable to consider the potential implications of plant viruses to human health and disease.”

Related Links:
University of Louisville



Print article

Channels

Drug Discovery

view channel
Image: Schematic diagram of dendrimer structure (Photo courtesy of the University of California, Irvine).

Dendrimer-Transported MicroRNA Shown Effective in Treating Mice with Late-Stage Liver Cancer

Cancer researchers have used nanocarriers called dendrimers to transport a specific tumor growth-inhibiting microRNA (miRNA) to the livers of mice with late-stage liver cancer. MicroRNAs are a class... Read more

Business

view channel

Purchase Agreement to Boost Ebola Vaccine Development

A deal to help boost development of a vaccine to protect against Ebolavirus infection was finalized at the recent Davos Conference in Switzerland. Gavi (Geneva, Switzerland), the global alliance for vaccines and immunizations, announced that it would spend five million USD to purchase the Ebola vaccine under development... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.